Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,133 total articles
Dyadic International, Inc. reported its Q2 2026 financial results showing continued commercialization progress across recombinant proteins and strategic OEM partnerships. The company advanced multiple product shipments, scale-up agreements, and global health initiatives using its proprietary C1 biomanufacturing platform. Despite increased costs and…
Cloudastructure, Inc., a NASDAQ-listed AI surveillance and security analytics company, has been awarded the installation contract for a third multifamily property with a longtime Baltimore developer. The initial phase includes installing approximately 70 cameras, with advanced AI surveillance and remote guarding services expected to be utilized aft…
Propanc Biopharma highlights its lead candidate PRP, a novel proenzyme therapy aiming to treat aggressive, treatment-resistant RAS-driven cancers by promoting cancer cell differentiation and reversing metastatic processes. PRP differs from current RAS inhibitors by targeting cancer stem cells and epithelial-mesenchymal transition rather than solely…
Exyn Technologies announced the formation of a Defense Advisory Board to enhance its efforts in securing and scaling autonomous technology programs with the U.S. and allied defense sectors. Andrew Knaggs, a former Deputy Assistant Secretary of Defense and decorated Green Beret, has been named the inaugural member. This move supports Exyn's recent g…
Aprea Therapeutics reported Q2 2026 financial results and provided updates on its clinical-stage oncology programs. Enrollment in the Phase 1 ACESOT-1051 trial of oral WEE1 inhibitor APR-1051 is accelerating with expansion to more clinical sites. Early data show promising anti-tumor activity and manageable tolerability. The company plans to advance…
Founder Group Limited has signed a RM5.58 million (US$1.37 million) contract to build a 1.78 MW rooftop solar system for a shrimp farming and processing facility in Kedah, Malaysia. This marks the company's second major aquaculture-focused renewable energy project, supporting Malaysia's growing aquaculture sector and national renewable energy goals…
PN Smart Energy Limited (NASDAQ: PN) announced that its subsidiary, Nanjing Cesun Power Development, has signed a framework agreement to acquire six rooftop solar projects totaling 9.9 MW in Ningbo, Zhejiang Province from Zhejiang Yuntan Technology. The acquisition, valued at approximately $4.45 million, is a key step in PN Smart's strategic transi…
Odysight.ai Inc., an AI-driven predictive maintenance solutions provider for defense and industrial sectors, announced its management team's participation in key investor conferences during Q3 2026, including the Sidoti Virtual Micro-Cap Conference and the H.C. Wainwright 28th Annual Global Investment Conference, to showcase its technology and enga…
SciSparc Ltd., through its majority-owned subsidiary NeuroThera Labs, announced that the Japanese Patent Office has granted a patent covering NeuroThera's proprietary pharmacological combination involving 4-aminophenol derivatives and N-acylethanolamines. The patent protects formulations aimed at enhancing the analgesic and antipyretic effects of 4…
Autonomix Medical, Inc. announced the successful completion of its Good Laboratory Practice (GLP) preclinical study, demonstrating positive safety and performance outcomes for its nerve-targeted treatment platform. This milestone supports upcoming FDA submission efforts and marks significant progress in the company’s development of innovative medic…
Scienture Holdings announces the commercial launch and initial order fulfillment of REZENOPY™, a 10 mg naloxone hydrochloride nasal spray, targeting the $143 million U.S. naloxone market. The product is backed by national sales efforts, payer coverage for 100 million lives, and access to over 5,000 healthcare facilities, aiming to expand institutio…
Safe Pro Group Inc. has entered a Cooperative Research and Development Agreement (CRADA) with the U.S. Army Engineer Research and Development Center to jointly develop AI-powered image analysis technologies leveraging uncrewed aerial systems. The partnership aims to enhance situational awareness solutions for military and civil uses, focusing on th…
Twin Disc, Inc. (NASDAQ: TWIN) announced the release date for its fiscal 2026 fourth-quarter earnings, set for August 20, 2026, along with a webcast and conference call to discuss the results. The company manufactures marine and heavy-duty off-highway power transmission equipment, serving multiple markets including marine, energy, military, and ind…
Bone Biologics Corporation announces the extension of the validated shelf life of its rhNELL-1 protein to 32 months, improving flexibility in manufacturing, storage, and distribution as it advances its pilot clinical study for spinal fusion applications. This milestone supports operational efficiency and supply chain flexibility for the company's l…
Madrigal Pharmaceuticals, a biopharmaceutical company specializing in treatments for metabolic dysfunction-associated steatohepatitis (MASH), announced the appointment of Dr. John C. Reed to its Board of Directors. Dr. Reed brings extensive leadership experience in drug discovery and development from his roles at Johnson & Johnson, Sanofi, and Roch…
Haoxi Health Technology Limited announced a reverse share split of its Class A and Class B ordinary shares at a ratio of 1-for-20 effective August 14, 2026. The split will reduce the number of outstanding shares and increase the share price accordingly on Nasdaq, where the stock trades under ticker HAO. No fractional shares will be issued; fraction…
Tri Pointe Homes, one of the largest homebuilders in the U.S., has been named to the 2026 PEOPLE Companies That Care list for the fourth consecutive year, underscoring its dedication to fostering a supportive workplace culture, employee empowerment, sustainable business practices, and community engagement. This recognition is based on extensive emp…
Fusion Fuel Green PLC announced that its subsidiary BrightHy Solutions has completed key execution milestones on two green hydrogen projects in Southern Europe, including the completion of the FEED package for a 15 MW green hydrogen production facility and successful factory acceptance tests for a hydrogen refueling station. These advances position…
SunScout Holding Limited, a New Zealand-based clean technology company specializing in autonomous solar-powered robotic mowers, has priced its initial public offering of 3.1 million shares at $5.00 each, raising $15.5 million before expenses. The shares will be dual-listed on NYSE American and NYSE Texas under the ticker SNSC. Proceeds will fund a …
Solana Company (NASDAQ: HSDT), a digital asset treasury and infrastructure firm focusing on the Solana ecosystem, announced it will release its second quarter 2026 operating results on August 14, 2026, followed by a management conference call to discuss the results and provide a business update.
NeOnc Technologies announced encouraging topline results from its Phase 2a study of intranasal NEO100 in patients with recurrent IDH1-mutant high-grade glioma. The study met its primary endpoint, with a six-month progression-free survival rate of 48.9%, significantly exceeding the 20% benchmark. Median overall survival was 26.09 months, with no maj…
LiqTech International, Inc. announced its second quarter 2026 financial results, reporting a decline in revenue to $4.4 million and net loss of $3.1 million. The company revised its full-year 2026 revenue guidance to $20-23 million, reflecting delays in a major Water for Energy project. LiqTech highlighted strong growth in Commercial Pool and Marin…
Avalyn Pharma announced the completion of patient enrollment for its global Phase 2b MIST trial evaluating AP01 for progressive pulmonary fibrosis. The trial overenrolled with 398 patients, and topline data are expected in late 2027. The company is also progressing Phase 2 AURA trial for AP02 and plans to initiate Phase 1 for AP03 by end of 2026. A…
High Roller Technologies, Inc., a publicly traded company on the NYSE, appoints Thomas Scaria, CFA, as its first Chief Product Officer to spearhead the development and launch of its ROLR prediction markets platform. The new role reflects the company's strategic focus on accelerating product innovation and market expansion in the real-money online g…
Century Therapeutics reported strong Q2 2026 results highlighting significant progress in its iPSC-derived cell therapy pipeline, including a positive pre-IND meeting with the FDA for CNTY-813 targeting type 1 diabetes functional cure and ongoing preparations for CNTY-308 clinical trials in B-cell diseases. The company established Phase 1 manufactu…
